Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes

Journal of Gene Medicine

Volumn 4, Issue 5, 2002, Pages 527-535

  Tomita, Naruya ^a   Morishita, Ryuichi ^a   Yamamoto, Kei ^a   Higaki, Jitsuo ^a   Dzau, Victor J ^b   Ogihara, Toshio ^a   Kaneda, Yasufumi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anti Thy 1 antibody; Gene therapy; HVJ liposome; NF B decoy; Tissue specific delivery

Indexed keywords

CYTOKINE; FLUORESCEIN ISOTHIOCYANATE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOLIPOSOME; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; DRUG CARRIER; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; GENE DELIVERY SYSTEM; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULUS; HISTOPATHOLOGY; MALE; METHODOLOGY; NONHUMAN; PARAINFLUENZA VIRUS 1; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; UPREGULATION; ANIMAL; DISEASE MODEL; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SECRETION; SENDAI VIRUS;

ANIMALIA; GLOMERULUS;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; GENE THERAPY; GLOMERULONEPHRITIS; KIDNEY GLOMERULUS; LIPOSOMES; NF-KAPPA B; RATS; SENDAI VIRUS;

EID: 0036728898     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.300     Document Type: Article

References (38)

1. Imai E, Isaka Y. Strategies of gene transfer to the kidney. Kidney Int 1998; 53: 264-272.
2. Imai E. Gene therapy for the treatment of renal disease: prospects for the future. Curr Opin Nephrol Hypertens 1997; 6 496-503.
3. Kaneda Y, Morishita R, Tomita N. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. J Mol Med 1995; 73: 289-297.
4. Kaneda Y, Saeki Y, Morishita R. Gene therapy using HVJ-liposomes: the best of both worlds? Mol Med Today 1999; 5 298-303.
5. Tomita N, Higaki J, Morishita R, et al. Direct in vivo gene introduction into rat kidney. Biochem Biophys Res Commun 1992; 186: 129-134.
6. Isaka Y, Fujiwara Y, Ueda N, et al. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet derived growth factor into the rat kidney. J Clin Invest 1993; 90: 2597-2601.
7. Morishita R, Gibbons GH, Ellison KE, et al. Single intraluminal delivery of antisense cdc2 kinase and PCNA oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci U S A 1993; 92: 8474-8479.
8. Tomita N, Morishita R, Higaki J, et al. Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen. Hypertension 1995; 26: 131-136.
9. Tomita N, Morishita R, Higaki J, et al. Effect of angiotensinogen on blood pressure regulation in normotensive rats; application of a loss of function approach. J Hypertens 1995; 13 1767-1774.
10. Morishita R, Gibbons GH, Ellison KE, et al. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest 1994; 93: 1458-1464.
11. Yamamoto T, Wilson CB. Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney Int 1987; 32: 514-525.
12. Bagchus WM, Hoedemaeker PJ, Rozing J, Bakker WW. Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. Lab Invest 1986; 55: 680-687.
13. Johnson RJ, Garcia RL, Pritzl P, Alpers CE. Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 1990; 136 369-374.
14. Lenardo MJ, Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue specific gene control. Cell 1989; 58: 227-229.
15. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-1071.
16. Tomita N, Horiuchi M, Tomita S, et al. An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro. Am J Physiol 1998; 275: F278-F284.
17. Tomita S, Tomita N, Yamada T, et al. Transcription factor decoy to study the molecular mechanism of negative regulation of renin gene expression in the liver in vivo. Circ Res 1999; 84 1059-1066.
18. Morishita R, Gibbons GH, Ellison KE, et al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci U S A 1995; 92: 5855-5859.
19. Kawamura I, Morishita R, Tsujimoto S, et al. Intravenous injection of oligodeoxynucleotides to the NF-kappaB biding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. Gene Ther 2001; 8: 905-912.
20. Lan HY, Paterson DJ, Atkins RC. Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int 1991; 40: 425-433.
21. Yoshimura A, Inui K, Nemoto T, et al. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis. J Am Soc Nephrol 1998; 9: 2027-2039.
22. Harper PA, Robinson JM, Hoover RL, Wright TC, Karnovsky MJ. Improved methods for culturing rat glomerular cells. Kidney Int 1984; 26: 875-880.
23. Moullier P, Friedlander G, Calise D, et al. Adenoviral-mediated gene transfer to renal tubular cells in vivo. Kidney Int 1994; 45: 1220-1225.
24. Heikkila P, Parpala T, Lukkarinen O, Weber M, Tryggvason K. Adenovirus-mediated gene transfer into kidney glomeruli using ex vivo and in vivo kidney perftision system: first steps towards gene therapy of Alport syndrome. Gene Ther 1996; 3: 21-27.
25. Zhu G, Nicolson A, Cowley B, Rosen S, Sukhatme V. In vivo adenovirus-mediated gene transfer into normal and cystic rat kidneys. Gene Ther 1996; 3: 298-304.
26. Paul LC, Rennke HG, Milford EL, Carpenter CB. Thy-1.1 in glomeruli of rat kidneys. Kidney Int 1984; 25: 771-777.
27. Bagchus WM, Jeunink MF, Elema JD. The mesangium in anti-Thy-1 nephritis. Influx of macrophages, mesangial cell hypercellularity, and macro-molecular accumulation. Am J Pathol 1990; 137: 215-223.
28. Sunderland CA, McMaster WR, Williams AF. Purification with monoclonal antibody of a predominant leukocyte-common antigen and glycoprotein from rat thymocytes. Eur J Immunol 1979; 9: 155-159.
29. Wang CY, Huang L. pH-sensitive immunoliposome mediates target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc Natl Acad Sci U S A 1987; 84: 7851-7855.
30. Liang KW, Hoffman EP, Huang L. Targeted delivery of plasmid DNA to myogenic cells via transferrin-conjugated peptide nucleic acid. Mol Ther 2000; 1: 236-243.
31. Aoki M, Morishita R, Higaki J, et al. Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and β-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area. Gene Ther 1997; 4: 120-127.
32. Tomita T, Hashimoto H, Tomita N, et al. In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes. Arthritis Rheum 1997; 40: 901-906.
33. Nishii T, Moriguchi A, Morishita R, et al. Angiotensinogen gene activating elements regulate blood pressure in the brain. Circ Res 1999; 85: 257-263.
34. Muroga K, Masuda Y, Ishizaki M, Sugisaki M, Yamanaka N. Experimental glomerulonephritis induced by a low dose of anti-Thy-1 antibody. Clin Exper Nephrol 1997; 1: 99-109.
35. Tomita N, Morishita R, Higaki J, Ogihara T. Strategy for functional inactivation of genes: a novel strategy for gene therapy and gene regulation analysis using transcription factor decoy oligonucleotides. Exp Nephrol 1997; 5: 429-434.
36. Tomita N, Morishita R, Tomita T, Ogihara T. Potential therapeutic applications of decoy oligonucleotides. Curr Opin Mol Ther 2002; in press.
37. Tomita N, Morishita R, Lan HY, et al. In vivo administration of a nuclear factor-kappaB decoy suppressed experimental crescentic glomerulonephritis. J Am Soc Nephrol 2000; 11: 1244-1252.
38. Tomita N, Morishita R, Tomita S, et al. Transcription factor decoy for NFκB inhibits TNF-α-induced cytokine and adhesion molecules expression in vivo. Gene Ther 2000; 7: 1326-1332.